Cite
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.
MLA
Colwell, Michael J., et al. “Pharmacological Targeting of Cognitive Impairment in Depression: Recent Developments and Challenges in Human Clinical Research.” Translational Psychiatry, vol. 12, no. 1, Nov. 2022, p. 484. EBSCOhost, https://doi.org/10.1038/s41398-022-02249-6.
APA
Colwell, M. J., Tagomori, H., Chapman, S., Gillespie, A. L., Cowen, P. J., Harmer, C. J., & Murphy, S. E. (2022). Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research. Translational Psychiatry, 12(1), 484. https://doi.org/10.1038/s41398-022-02249-6
Chicago
Colwell, Michael J, Hosana Tagomori, Sarah Chapman, Amy L Gillespie, Philip J Cowen, Catherine J Harmer, and Susannah E Murphy. 2022. “Pharmacological Targeting of Cognitive Impairment in Depression: Recent Developments and Challenges in Human Clinical Research.” Translational Psychiatry 12 (1): 484. doi:10.1038/s41398-022-02249-6.